Posts by: Patricia Inacio, PhD

Patricia Inacio, PhD

August 14, 2015August 14, 2015

G1 Therapeutics Drug With Protective Effect Against Chemotherapy Tested in New Lung Cancer Clinical Trial

Lung Cancer, News

G1 Therapeutics, a clinical-stage company developing small-molecule based therapies for cancer patients, announced the initiation of two clinical trials testing their new therapy for protecting small-cell lung cancer patients undergoing chemotherapy. ... Read more

August 10, 2015August 10, 2015

Pseudomonas Aeruginosa Found To Change Microbiota Respiratory Tract in CF Patients

News

In a recent study entitled “Insights into the respiratory tract microbiota of patients with cystic fibrosis during early Pseudomonas aeruginosa colonization,” researchers investigated the impact of Pseudomonas aeruginosa presence on the ... Read more

August 6, 2015November 5, 2015

Serum Autoantibodies Profile Not a Biomarker for Survival in Systemic Sclerosis-PAH Patients

News, Pulmonary Hypertension

In a new study entitled “Survival in systemic sclerosis–pulmonary arterial hypertension by serum autoantibody status in the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS) Registry,” the authors ... Read more

August 6, 2015November 9, 2015

New Observations Made in Asthma-COPD Overlap Syndrome (ACOS) Patients

COPD, News

In a new study entitled “Unraveling the Pathophysiology of the Asthma-COPD Overlap Syndrome: Unsuspected Mild Centrilobular Emphysema Is Responsible for Loss of Lung Elastic Recoil in Never Smokers With Asthma ... Read more

August 3, 2015November 9, 2015

Aclidinium/formoterol Therapy Reduces COPD Patients’ Exacerbations

COPD, News

In a new study entitled “Aclidinium bromide and formoterol fumarate as a fixed-dose combination in COPD: pooled analysis of symptoms and exacerbations from two six-month, multicentre, randomized studies (ACLIFORM and ... Read more

July 31, 2015July 31, 2015

New Mechanism Underlying Lung Cancer Therapeutics Resistance Discovered

Lung Cancer, News

In two novel reports entitled “MicroRNA-148a reduces tumorigenesis and increases TRAIL-induced apoptosis in NSCLC” and “A set of NF-κB–regulated microRNAs induces acquired TRAIL resistance in Lung cancer” published in the ... Read more

July 30, 2015July 30, 2015

Increases in Telomere Length Associated With Double Risk for Lung Cancer

Lung Cancer, News

In a new study entitled “Genetic determinants of telomere length and risk of common cancers: a Mendelian randomization study,” researchers report that long telomeres are associated with an increased risk ... Read more

July 29, 2015November 6, 2015

Rheumatoid Arthritis-Bronchiectasis Patients Exhibit Increase in Disease Severity

Bronchiectasis, News

In a new study entitled “Increased disease activity, severity and autoantibody positivity in rheumatoid arthritis patients with co-existent bronchiectasis” researchers measured key markers of rheumatoid arthritis disease activity and severity in ... Read more

July 27, 2015November 9, 2015

Researchers Connect Low Levels of Anti-Inflammatory CC16 Protein With COPD Patients’ Lung Decline

COPD, News

In a recent study entitled “Relation between circulating CC16 concentrations, lung function, and development of chronic obstructive pulmonary disease across the lifespan: a prospective study,” researchers report preliminary data that ... Read more

July 23, 2015November 6, 2015

Systemic Sclerosis Patients Found To Have Higher Risk for Temporomandibular Joint Disorder

News, Scleroderma

In a recent study, researchers observed that temporomandibular joint disorder is common in Systemic Sclerosis patients, correlating with disease severity. The findings were presented at the European League Against Rheumatism Annual European ... Read more